UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K
                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

                Date of Report (date of earliest event reported):
                                  April 4, 2007


                               CHEMED CORPORATION
             (Exact name of registrant as specified in its charter)


    Delaware                        1-8351                        31-0791746
(State or other            (Commission File Number)            (I.R.S. Employer
 jurisdiction of                                                 Identification
 incorporation)                                                      Number)


          2600 Chemed Center, 255 East 5th Street, Cincinnati, OH 45202
               (Address of principal executive offices) (Zip Code)


               Registrant's telephone number, including area code:
                                 (513) 762-6900



                                   Page 1 of 2



Item 8.01 Other Events

          The Registrant announced April 4, 2007, that it issued a notice of
     redemption, to redeem on May 4, 2007, subject to the satisfaction or waiver
     of the condition referred to below, the entire $150 million aggregate
     principal amount of its 8-3/4% Senior Notes due 2011 (Notes). This
     redemption is being made pursuant to the terms of the indenture dated
     February 24, 2004 at a redemption price of 104.375% of the principal amount
     of the Notes together with accrued but unpaid interest.

          This redemption is contingent upon the completion of one or more
     financing transactions by the Company prior to May 4, 2007, with terms that
     are reasonably satisfactory to the registrant. Accordingly, redemption will
     not occur, and none of the Notes will be deemed due and payable, on May 4,
     2007, unless this financing condition is satisfied or waived by Chemed.

          On the redemption date, assuming satisfaction or waiver of the
     financing condition, the redemption price will become due and payable on
     all outstanding Notes. Upon redemption, interest on the Notes will cease to
     accrue on and after the redemption date, and the only remaining right of
     the holders of the Notes after such date will be to receive payment of the
     redemption price and accrued interest upon surrender of the Notes

          If and when the redemption is completed the Company will incur a
     pretax charge of $11.5 million, comprising the write-off of deferred
     financing and other costs ($4.9 million) related to the Notes and the
     payment of the 4.375% redemption premium ($6.6 million). This charge will
     be classified as a loss on extinguishment of debt in the consolidated
     statement of income.


Item 9.01 Financial Statements and Exhibits.

          c) Exhibits
               (99.1) Registrant's press release dated April 4, 2007.

               (99.2) Registrant's Notice of Redemption dated April 4, 2007.


                                   SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.

                                               CHEMED CORPORATION


Dated:  April 5, 2007                          By: /s/ Arthur V. Tucker, Jr.
       ---------------                             -------------------------
                                                   Arthur V. Tucker, Jr.
                                                   Vice President and Controller



                                   Page 2 of 2